2-methyl-1-(2,3,4,5,6-pentadeuteriophenyl)propan-2-amine:hydrochloride
- CAS No.
- 1330236-21-9
- Chemical Name:
- 2-methyl-1-(2,3,4,5,6-pentadeuteriophenyl)propan-2-amine:hydrochloride
- Synonyms
- Phentermine-d5 HCl (phenyl-d5);Phentermine-d5 (hydrochloride) (CRM);Phentermine-d5 hydrochloride (phenyl-d5);2-methyl-1-(2,3,4,5,6-pentadeuteriophenyl)propan-2-amine:hydrochloride
- CBNumber:
- CB53758958
- Molecular Formula:
- C10H11ClD5N
- Molecular Weight:
- 190.72454889
- MDL Number:
- MOL File:
- 1330236-21-9.mol
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() ![]() ![]() GHS02,GHS06,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H301+H311+H331-H370 | |||||||||
| Precautionary statements | P210-P240-P241-P242-P243-P260-P264-P270-P271-P280-P301+P310-P321-P330-P303+P361+P353-P304+P340-P307+P311-P312-P361+P364-P370+P378-P403+P233-P403+P235-P405-P501 | |||||||||
| NFPA 704 |
|
2-methyl-1-(2,3,4,5,6-pentadeuteriophenyl)propan-2-amine:hydrochloride price More Price(5)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | ISO60199 | Phentermine-d5 (hydrochloride) (CRM) | 1330236-21-9 | 1mg | $266 | 2026-04-30 | Buy |
| Biosynth | FDC23621 | Phentermine-d5 hydrochloride | 1330236-21-9 | 5mg | $1431.15 | 2026-06-04 | Buy |
| Biosynth | FDC23621 | Phentermine-d5 hydrochloride | 1330236-21-9 | 10mg | $1991.1 | 2026-06-04 | Buy |
| Biosynth | FDC23621 | Phentermine-d5 hydrochloride | 1330236-21-9 | 25mg | $3733.5 | 2026-06-04 | Buy |
| Biosynth | FDC23621 | Phentermine-d5 hydrochloride | 1330236-21-9 | 50mg | $5973 | 2026-06-04 | Buy |
2-methyl-1-(2,3,4,5,6-pentadeuteriophenyl)propan-2-amine:hydrochloride Chemical Properties, Uses, Production
Description
Phentermine-d5 (CRM) is intended for use as an internal standard for the quantification of phentermine by GC- or LC-mass spectrometry. Phentermine is an α-methylated amphetamine that activates trace amine associated receptor 1 (TAAR1, EC50 = 5.47 μM). It potently stimulates the release of norepinephrine (IC50 = 39.4 nM), with less effect on the release of dopamine and serotonin (IC50s = 262 and 3,511 nM, respectively). Primarily through these actions, phentermine suppresses appetite and augments fat metabolism, supporting usefulness in ameliorating obesity.
Uses
Labelled Phentermine (P318830). An Amphetamine derivative.Controlled substance (stimulant). Anorexic.
References
[1] SEAN MANNING Nicholas F Andrea Pucci. Pharmacotherapy for obesity: novel agents and paradigms.[J]. Therapeutic Advances in Chronic Disease, 2014, 5 3: 135-148. DOI: 10.1177/2040622314522848
[2] NADIA FUCCI Nadia D G. Adulterants encountered in the illicit cocaine market[J]. Forensic science international, 1998, 95 3: Pages 247-252. DOI: 10.1016/s0379-0738(98)00102-9







